Key facts
- This page summarizes Pedro J. Lasanta's Form 4 filing for Pharma-Bio Serv, Inc. (PBSV).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 08 Mar 2023, 15:23.
Pedro J. Lasanta - 06 Mar 2023 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- PBSV
- Reported as of
- 06 Mar 2023
- Net transaction value
- -$0.6
- SEC form
- 4
- Accepted by SEC
- 08 Mar 2023, 15:23:24 UTC
- Prior SEC filing
- 13 Dec 2021
- Next SEC filing
- 28 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Pedro J. Lasanta
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Pedro J. Lasanta filed Form 4 for Pharma-Bio Serv, Inc. (PBSV) on 08 Mar 2023.
Change
- Previous filing in this sequence was filed on 13 Dec 2021.
- Current net transaction value: -$0.6.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PBSV
transaction
Common Stock
Options Exercise
- Transaction value
- $88,000
- Shares
- +100,000
- Change %
- +106%
- Price
- $0.8800
- Shares after
- 194,552
- Date
- 06 Mar 2023
- Ownership
- Direct
PBSV
transaction
Common Stock
Tax liability
- Transaction value
- $88,000
- Shares
- -76,522
- Change %
- -39%
- Price
- $1.15
- Shares after
- 118,030
- Date
- 06 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
PBSV
transaction
Common Stock
Options Exercise
- Transaction value
- $8,242
- Shares
- +8,325
- Change %
- +7.1%
- Price
- $0.9900
- Shares after
- 126,355
- Date
- 06 Mar 2023
- Ownership
- Direct
PBSV
transaction
Common Stock
Tax liability
- Transaction value
- $8,242
- Shares
- -7,167
- Change %
- -5.7%
- Price
- $1.15
- Shares after
- 119,188
- Date
- 06 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PBSV
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.8800
- Footnotes
- F2
PBSV
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -8,325
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 16,675
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,325
- Exercise price
- $0.9900
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
Footnote F2
The stock option vested in three equal annual installments beginning on October 4, 2020.
Footnote F3
On December 9, 2021, the reporting person was granted a stock option to purchase 25,000 shares, which stock option vests in three equal installments beginning on December 9, 2022.